Free Trial

(MDVN) (MDVN) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Notable ETF Outflow Detected - HYLB
Medivation Alzheimer's Drug Fails Pivotal Study
Core Medalist ETFs
The Connor Phillips Show
Medivation Stock Hits New 52-Week High (MDVN)
Analysts Holding As Pfizer Waits On Two Phase 3 Studies (MDVN)
Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.
Medivation (MDVN) Stock Surges, Will Explore Sale
2 Longs and 2 Shorts to Watch in the Stock Market
Get (MDVN) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDVN and its competitors with MarketBeat's FREE daily newsletter.

The Only Energy Play You Should Be Looking At (Ad)

Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.

Click here to get all the information about it.

MDVN Media Mentions By Week

MDVN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MDVN
News Sentiment

0.00

0.94

Average

News Sentiment

MDVN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MDVN Articles
This Week

0

0

MDVN Articles
Average Week

Get (MDVN) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDVN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MDVN) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners